Centessa Pharmaceuticals plc American Depositary Receipt (CNTA) at a glance

Centessa Pharmaceuticals plc American Depositary Receipt (CNTA) is a mid-cap Healthcare company. It trades at $40.5, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 37/100 overall. Its strongest dimension is Momentum (87/100) and its weakest is Growth (10/100). Its volatility is roughly in line with the market.

Price

$40.50

Market cap

$6.15B

P/E ratio

n/a

Dividend yield

None

Beta

1.12

52-week range

$12.78 to $40.56